Citations (46)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (2)
Yifrah Kaminer, Pablo Goldberg & DanielF. Connor. (2010) Psychotropic Medications and Substances of Abuse Interactions in Youth. Substance Abuse 31:1, pages 53-57.
Read now
Read now
Martin LaBarbera & Toni Wolfe. (1983) Characteristics, Attitudes and Implications of Fentanyl Use Based on Reports from Self-Identified Fentanyl Users. Journal of Psychoactive Drugs 15:4, pages 293-301.
Read now
Read now
Articles from other publishers (44)
Grant C. Glatfelter, Marthe M. Vandeputte, Li Chen, Donna Walther, Meng-Hua M. Tsai, Lei Shi, Christophe P. Stove & Michael H. Baumann. (2023) Alkoxy chain length governs the potency of 2-benzylbenzimidazole ‘nitazene’ opioids associated with human overdose. Psychopharmacology 240:12, pages 2573-2584.
Crossref
Crossref
Elliot W. McClure & R. Nathan Daniels. (2023) Classics in Chemical Neuroscience: Dextromethorphan (DXM). ACS Chemical Neuroscience 14:12, pages 2256-2270.
Crossref
Crossref
M.L. Shawn Bates & Keith A. Trujillo. (2023) Repeated dextromethorphan administration in adolescent rats produces long-lasting behavioral alterations. Pharmacology Biochemistry and Behavior 227-228, pages 173581.
Crossref
Crossref
Michael Evans-Brown, Brendan Hughes & Roumen Sedefov. 2022. Novel Psychoactive Substances. Novel Psychoactive Substances
3
56
.
Peter Blanckaert, Margot Balcaen, Céline Vanhee, Martijn Risseeuw, Michaël Canfyn, Bart Desmedt, Serge Van Calenbergh & Eric Deconinck. (2021) Analytical characterization of “etonitazepyne,” a new pyrrolidinyl‐containing 2‐benzylbenzimidazole opioid sold online. Drug Testing and Analysis 13:9, pages 1627-1634.
Crossref
Crossref
Peter Reuter, Bryce Pardo & Jirka Taylor. (2021) Imagining a fentanyl future: Some consequences of synthetic opioids replacing heroin. International Journal of Drug Policy 94, pages 103086.
Crossref
Crossref
Bryce Pardo, Jirka Taylor, Jon Caulkins, Peter Reuter & Beau Kilmer. (2020) The dawn of a new synthetic opioid era: the need for innovative interventions. Addiction 116:6, pages 1304-1312.
Crossref
Crossref
Marthe M. Vandeputte, Katleen Van Uytfanghe, Nathan K. Layle, Danielle M. St. Germaine, Donna M. Iula & Christophe P. Stove. (2021) Synthesis, Chemical Characterization, and μ-Opioid Receptor Activity Assessment of the Emerging Group of “Nitazene” 2-Benzylbenzimidazole Synthetic Opioids. ACS Chemical Neuroscience 12:7, pages 1241-1251.
Crossref
Crossref
Peter Blanckaert, Annelies Cannaert, Katleen Van Uytfanghe, Fabian Hulpia, Eric Deconinck, Serge Van Calenbergh & Christophe Stove. (2020) Report on a novel emerging class of highly potent benzimidazole NPS opioids: Chemical and in vitro functional characterization of isotonitazene. Drug Testing and Analysis 12:4, pages 422-430.
Crossref
Crossref
Lorella Pasquinucci, Carmela Parenti, Emanuele Amata, Zafiroula Georgoussi, Paschalina Pallaki, Valeria Camarda, Girolamo Calò, Emanuela Arena, Lucia Montenegro & Rita Turnaturi. (2018) Synthesis and Structure-Activity Relationships of (−)-cis-N-Normetazocine-Based LP1 Derivatives. Pharmaceuticals 11:2, pages 40.
Crossref
Crossref
Rita Turnaturi, Agostino Marrazzo, Carmela Parenti & Lorella Pasquinucci. (2018) Benzomorphan scaffold for opioid analgesics and pharmacological tools development: A comprehensive review. European Journal of Medicinal Chemistry 148, pages 410-422.
Crossref
Crossref
Michael Evans-Brown & Roumen Sedefov. 2018. New Psychoactive Substances. New Psychoactive Substances
3
49
.
Audrey Redford. (2016) Don’t eat the brown acid: Induced ‘malnovation’ in drug markets. The Review of Austrian Economics 30:2, pages 215-233.
Crossref
Crossref
Nafiseh Shekari, Maryam Vosough & Kourosh Tabar Heidar. (2017) Chemometrics-assisted chromatographic fingerprinting: An illicit methamphetamine case study. Journal of Separation Science 40:6, pages 1318-1326.
Crossref
Crossref
Michael Evans-Brown & Roumen Sedefov. (2017) New psychoactive substances: driving greater complexity into the drug problem. Addiction 112:1, pages 36-38.
Crossref
Crossref
Emanuela Vitale. 2017. Molecular Technologies for Detection of Chemical and Biological Agents. Molecular Technologies for Detection of Chemical and Biological Agents
283
287
.
Peter H. Reuter & Bryce A. Pardo. 2017. Novel Psychoactive Substances. Novel Psychoactive Substances
155
177
.
Maria Katselou, Ioannis Papoutsis, Panagiota Nikolaou, Samir Qammaz, Chara Spiliopoulou & Sotiris Athanaselis. (2016) Fenethylline (Captagon) Abuse - Local Problems from an Old Drug Become Universal. Basic & Clinical Pharmacology & Toxicology 119:2, pages 133-140.
Crossref
Crossref
Matthias M. Herth & Gitte M. Knudsen. (2015)
Current radiosynthesis strategies for 5-HT
2A
receptor PET tracers
. Journal of Labelled Compounds and Radiopharmaceuticals 58:7, pages 265-273.
Crossref
Crossref
Jason Wallach, Pierce V. Kavanagh, Gavin McLaughlin, Noreen Morris, John D. Power, Simon P. Elliott, Marion S. Mercier, David Lodge, Hamilton Morris, Nicola M. Dempster & Simon D. Brandt. (2015) Preparation and characterization of the ?research chemical? diphenidine, its pyrrolidine analogue, and their 2,2-diphenylethyl isomers. Drug Testing and Analysis 7:5, pages 358-367.
Crossref
Crossref
Tomi Lintonen, Anne Konu, Sanna Rönkä & Elina Kotovirta. (2014) Drugs foresight 2020: a Delphi expert panel study. Substance Abuse Treatment, Prevention, and Policy 9:1.
Crossref
Crossref
Simon D. Brandt, Leslie A. King & Michael Evans‐Brown. (2014) The new drug phenomenon. Drug Testing and Analysis 6:7-8, pages 587-597.
Crossref
Crossref
Hamilton Morris & Jason Wallach. (2014) From PCP to MXE: a comprehensive review of the non‐medical use of dissociative drugs. Drug Testing and Analysis 6:7-8, pages 614-632.
Crossref
Crossref
Michael W. White & John R.H. Archer. 2013. Novel Psychoactive Substances. Novel Psychoactive Substances
233
259
.
Donald G. Barceloux. 2012. Medical Toxicology of Drug Abuse. Medical Toxicology of Drug Abuse
527
538
.
F. Ivy Carroll, Anita H. Lewin, S. Wayne Mascarella, Herbert H. Seltzman & P. Anantha Reddy. (2012) Designer drugs: a medicinal chemistry perspective. Annals of the New York Academy of Sciences 1248:1, pages 18-38.
Crossref
Crossref
Louis A. Pagliaro & Ann Marie Pagliaro. 2011. Handbook of Child and Adolescent Drug and Substance Abuse. Handbook of Child and Adolescent Drug and Substance Abuse
371
453
.
Zong‐Yi You, Yi‐Jing Chen, Yu‐Yun Wang & Chinpiao Chen. (2013) Synthesis of Deuterium Labeled Standards of 1‐Benzylpiperazine, Fenetylline, Nicocodeine and Nicomorphine. Journal of the Chinese Chemical Society 55:3, pages 663-667.
Crossref
Crossref
Kenzie Preston, John Schmittner, David Epstein & Sharon Walsh. 2007. Pharmacokinetics and Pharmacodynamics of Abused Drugs. Pharmacokinetics and Pharmacodynamics of Abused Drugs
143
173
.
Stephen Heishman. 2006. Drug Abuse Handbook, Second Edition. Drug Abuse Handbook, Second Edition
207
311
.
. 2005. Drug Metabolism. Drug Metabolism
41
128
.
Edward W. Boyer. (2004) Dextromethorphan Abuse. Pediatric Emergency Care 20:12, pages 858-863.
Crossref
Crossref
Linda D. Marsh, Janice D. Key & Eve Spratt. (1997) Bulimia and dextromethorphan abuse. Journal of Substance Abuse Treatment 14:4, pages 373-376.
Crossref
Crossref
William H. Soine. (2006) Clandestine drug synthesis. Medicinal Research Reviews 6:1, pages 41-74.
Crossref
Crossref
John P. Thompson, M. Douglas Anglin, William Emboden & Dennis Gene Fisher. (1995) Mushroom Use by College Students. Journal of Drug Education 15:2, pages 111-124.
Crossref
Crossref
Richard Wilmot. (1985) Euphoria. Journal of Drug Issues 15:2, pages 155-191.
Crossref
Crossref
T.F. Murray & M.E. Leid. (1984) Interaction of dextrorotatory opioids with phencyclidine recognition sites in rat brain membranes. Life Sciences 34:20, pages 1899-1911.
Crossref
Crossref
R. W. Ashworth, E. W. J. de Maar, S. Johne, Y. V. Natochin, M. Nath Pal, S. K. Puri, G. P. Dutta, A. Scriabine, D. G. Taylor, E. Hong, S. Sharma, E. S. Charles, E. K. Weisburger & W. D. WintersS. Johne. 1982. Progress in Drug Research / Fortschritte der Arzneimittelforschung / Progrès des recherches pharmaceutiques. Progress in Drug Research / Fortschritte der Arzneimittelforschung / Progrès des recherches pharmaceutiques
259
341
.
Keith BaileyDonald Legault. (1981) Carbon-13 Nuclear Magnetic Resonance Spectra of Trimethoxyamphetamines?A Comparison of Predicted with Experimental Results. Journal of Forensic Sciences 26:2, pages 11370J.
Crossref
Crossref
Richard T. RappoltSrSr, George R. Gay, Walter J. Decker & Darryl S. Inaba. (1980) NAGD regimen for the coma of drug-related overdose. Annals of Emergency Medicine 9:7, pages 357-363.
Crossref
Crossref
K.W. Hindmarsh, N.W. Hamon, D.F. LeGatt & S.M. Wallace. (1978) Effect of Diphenhydramine on Methaqualone Metabolism: An In Vitro Study. Journal of Pharmaceutical Sciences 67:11, pages 1547-1550.
Crossref
Crossref
Keith Bailey. (1978) Identification of a Street Drug as N-Ethyl-1-phenylcyclohexylamine, a Phencyclidine Analog. Journal of Pharmaceutical Sciences 67:6, pages 885-886.
Crossref
Crossref
Thomas H. Bewley. 1977.
57
63
.
Audrey Redford. (2015) Don't Eat the Brown Acid: Induced Malnovationn in Drug Markets. SSRN Electronic Journal.
Crossref
Crossref